Marlene Schank
Nurse Practitioner · Marlette, MINPI 1235467887
Payments from drug & device makers
Across 85 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$390
- Mylan Specialty L.p.$190
- Lilly USA, LLC$185
- GSK$164
- AbbVie$112
- Axsome Therapeutics, Inc.$105
- plus $472 from 13 others
What the payments were for
- Food & beverage$1,617100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $390 |
| Mylan Specialty L.p. | 10 | $190 |
| Lilly USA, LLC | 11 | $185 |
| GSK | 10 | $164 |
| AbbVie | 5 | $112 |
| Axsome Therapeutics, Inc. | 4 | $105 |
| SK Life Science, Inc. | 1 | $80 |
| Amgen(2 entities) | 3 | $59 |
| Sanofi Pasteur Inc. | 3 | $49 |
| Pfizer | 3 | $46 |
| Exact Sciences | 3 | $46 |
| Dexcom, Inc. | 2 | $34 |
| Novartis | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Boston Scientific | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Vertex | 1 | $17 |
| Merck | 1 | $12 |
How this compares
$1,617 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $44,113 |
| EliquisApixaban | 41 | $30,931 |
| TrulicityDulaglutide | 24 | $30,753 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $23,356 |
| RybelsusSemaglutide | 12 | $17,577 |
| OzempicSemaglutide | 16 | $15,060 |
| JardianceEmpagliflozin | 13 | $14,802 |
| Aripiprazole | 12 | $5,582 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 44 | $3,720 |
| Atorvastatin Calcium | 218 | $2,446 |
| Metformin Hcl | 134 | $1,300 |
| Lisinopril | 170 | $1,289 |
| Levothyroxine Sodium | 97 | $1,228 |
| Omeprazole | 97 | $1,206 |
| SynthroidLevothyroxine Sodium | 13 | $1,199 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $185 | $74,86768 claims |
| Novo NordiskRybelsus, Ozempic | $390 | $32,63728 claims |
| PfizerEliquis | $46 | $30,93141 claims |
| GSKTrelegy Ellipta | $164 | $23,35634 claims |
| Boehringer IngelheimJardiance | $20 | $14,80213 claims |
| AbbVieSynthroid | $112 | $1,19913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Marlette
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.